DEDaria G. Eremich

Daria G. Eremich

*This is an algorithmically generated author record based on publicly available information.

Daria G. Eremich has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparative evaluation of the efficacy of semi-elemental and polymeric nutritional formulas in combination with serotonin for the correction of nutritional status disorders and gastrointestinal insufficiency in the postoperative period in oncological patients: results of a pilot study

    by I.S. Simutis, D.G. Eremich, K. Blitsõn, D.S. Salygina, M.S. Danilov, A.A. Sapegin, L.B. Gaikovaya

    Objective. To improve perioperative outcomes in patients with malignant GIT tumors and pre-existing NI through early use of a semi-elemental therapeutic formula in combination with continuous infusion of serotonin adipinate. Material and methods. This was a prospective, randomized, single-center pilot study including 44 patients aged >65 years after elective GIT surgery for malignant neoplasms with documented NI (≥2 points on NRS-2002) and GII (≥3 points on the LIFE scale). All patients received a low-rate intravenous infusion of serotonin adipinate (20 mg/day) until resolution of GII. Early enteral nutritional support was initiated simultaneously: in the main group, a semi-elemental whey protein hydrolysate-based formula (Peptamen Intense) was used; in the control group, a standard polymeric formula (Nutricomp Intensive) was administered. The severity of GII was assessed using the LIFE scale; plasma serotonin levels, amino acid profile (methionine, arginine, valine, citrulline, etc.), laboratory markers of nutritional status and their dynamics were evaluated on postoperative days 1, 2, and 5. Results. In both groups, serotonin supplementation led to a rapid normalization of initially reduced plasma serotonin levels (from 49.8 ng/mL [19; 71.2] to values within the reference range already by postoperative day 1, with subsequent stabilization). In the main group, the semi-elemental formula provided a more pronounced nutritional effect: by day 5 there was a significant restoration (p<0.05) of initially decreased methionine, arginine, and valine concentrations compared with the control group. A less pronounced catabolic trend was observed for citrulline, a marker of functional enterocyte mass, along with a more favorable course of GII according to the LIFE scale (p<0.05) in the main group. Significant negative correlations were identified between GII severity and arginine levels (r=–0.994; 95% CI [–0.9968; –0.9890], p=0.01) and citrulline levels (r=–0.614; 95% CI [–0.819; –0.271], p=0.04), indicating active utilization of these amino acids in reparative processes under combined therapy. Conclusion. The results of this pilot study demonstrate the potential of early use of a semi-elemental enteral formula on the background of prokinetic therapy with serotonin adipinate to optimize postoperative restoration of GIT function and correction of malnutrition in oncologic patients with pre-existing NI and GII. The data obtained indicate a more favorable dynamics of the amino acid profile (methionine, arginine, valine, citrulline) and a trend toward less severe GII on the LIFE scale compared with a standard polymeric formula. However, given the small sample size and short follow-up period, these findings require confirmation in larger multicenter studies.


  • Open Access

    Serotonin as a means of preventing gastrointestinal failure in the early postoperative period: a randomized clinical study

    by Daria G. Eremich, Ionas S. Simutis, Mark S. Danilov, Daria S. Salygina, Kristina Blitsyn

    BACKGROUND: In patients with gastrointestinal cancers, preoperative malnutrition is associated with decreased plasma serotonin levels and an increased risk of gastrointestinal failure in the postoperative period. AIM: The work aimed to evaluate the safety and clinical efficacy of serotonin compared with standard prokinetic therapy for the correction of gastrointestinal failure in patients with malnutrition. METHODS: It was a randomized pilot clinical study including 42 patients aged ≥ 65 years after elective gastrointestinal surgery for cancer. All participants had malnutrition (NRS 2002 ≥ 2) and gastrointestinal failure (LIFE ≥ 2). Patients were randomized as follows: the main group (n = 24) received serotonin at a dose of 20 mg/day intravenously until gastrointestinal failure is resolved; the control group (n = 18) received standard therapy (metoclopramide, 10 mg, and neostigmine methyl sulfate, 0.1 mg, three times daily). Both groups received standardized enteral nutritional support with a semi-elemental formula. Changes in LIFE scores, plasma serotonin and albumin levels, inflammatory markers, hemostasis parameters (piezoelectric thromboelastography), and the incidence of thrombotic complications were assessed. Thromboprophylaxis was performed with enoxaparin sodium, 40 mg/day, administered subcutaneously. RESULTS: Baseline characteristics of the groups did not differ significantly. Serotonin levels were decreased in both groups (50.37 ng/mL in the control group; 51.6 ng/mL in the main group; p = 0.782). During serotonin administration, its concentration was maintained within the reference range, whereas in the control group it continued to decrease by day 2. By day 5, the severity of gastrointestinal failure according to the LIFE scale was significantly lower in the main group (0.3 vs 2.6 points; p = 0.045), which was accompanied by earlier recovery of peristalsis and bowel movements. A strong negative correlation was found between serotonin levels and the severity of gastrointestinal failure (rs = −0.69; p = 0.012). In patients receiving serotonin, hypoalbuminemia was corrected more rapidly (p = 0.0057); albumin levels also negatively correlated with the severity of gastrointestinal failure (rs = −0.71; p = 0.010). Inflammatory markers and hemostasis parameters did not differ between the groups. Thrombotic events were not observed in either group. CONCLUSION: In patients with gastrointestinal cancers and preoperative malnutrition, serotonin as part of complex therapy for gastrointestinal failure was associated with faster resolution and correction of hypoalbuminemia without signs of increased inflammatory response or an increased risk of thrombotic events.

  • Gastrointestinal failure in postoperative period

    by D.G. Eremich, I.S. Simutis, I.E. Khoroshilov, E.A. Shishkina, A.A. Sapegin

    The review is devoted to postoperative gastrointestinal insufficiency, diagnosis and modern therapeutic approaches. Special attention is paid to the most vulnerable groups of patients, as well as to clinical variants of this pathological process. Modern therapeutic strategies are highlighted taking into account the most significant pathogenetic mechanisms. The key areas for perspective research are outlined.

  • Serotonin and intestinal insufficiency in the perioperative period

    by D. G. Eremich, I. S. Simutis, M. S. Danilov, D. S. Salygina, V. A. Ratnikov

    The review is devoted to the problem of postoperative intestinal insufficiency: one of the probable pathophysiological bases of this condition, serotonin deficiency, is considered. The problems of intestinal insufficiency from the point of view of functional and structural disorders of the intestine are considered in detail, the relationship of this condition with the synthesis and metabolism of serotonin is analyzed. Special attention is paid to the accumulated clinical experience in the treatment of intestinal insufficiency through the donation of parenteral serotonin preparations, the advantages and side effects of such therapy, as well as possible complications, are considered in detail. In this regard, emphasis is placed on the most rational and effective approaches to the correction of serotonin deficiency in the treatment of functional intestinal insufficiency of the perioperative period.